{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:09:40Z","timestamp":1788286180568,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019559","name":"Carl von Ossietzky Universit\u00e4t Oldenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019559","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The diagnosis of Alzheimer\u2019s disease (AD) is based on the presence of characteristic biomarkers and the presence of a clinical AD phenotype. Since pathological changes typically begin years before a formal diagnosis, early detection is an important objective in AD research. Literature suggests that especially cognitive tests for assessing relational memory and memory tests requiring discrimination between previously learned and similar novel stimuli, are indicative of early AD-related cognitive impairment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>288 memory clinic patients were divided into three Mini-Mental State Examination (MMSE) groups: Group A (MMSE 27\u201330), Group B (MMSE 23\u201326), Group C (MMSE 18\u201322). Logistic regression analyses were conducted to evaluate the ability of seven neuropsychological tests, selected for their clinical relevance in diagnosing AD and distinguishing it from differential diagnoses, to predict whether a patient has AD according to their cerebrospinal fluid profile (AD+) or another neurodegenerative disease\/ another dementia syndrome (AD-), for the three MMSE groups separately.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The model\u2019s classification accuracy decreased from 83.78% in Group A to 72.92% in Group B and 75.81% in Group C. In Group A, significant predictors included Paired-Associate Learning (PAL), with AD+ patients performing worse; Phonemic Fluency (PhonoWF) and Beck\u2019s Depression Inventory (BDI). PhonoWF and BDI are related to impairments of the AD- group: AD- patients showed a poorer test performance and more depressive symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Predictive value of neuropsychological tests varies with the stage of cognitive impairment. Integrating relational memory tasks, such as PAL, enhances the utility of neuropsychological assessments in early identification of clinical AD phenotypes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-026-04742-7","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T05:05:37Z","timestamp":1772773537000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cognitive tests distinguish biomarker-verified early Alzheimer\u2019s disease from other patients"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0462-8095","authenticated-orcid":false,"given":"Franziska","family":"Kiene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8759-6005","authenticated-orcid":false,"given":"Annika","family":"Notbohm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6015-3194","authenticated-orcid":false,"given":"Mandy","family":"Roheger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3942-0697","authenticated-orcid":false,"given":"Thomas","family":"Duning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9659-1671","authenticated-orcid":false,"given":"Helmut","family":"Hildebrandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"4742_CR1","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","volume":"20","author":"B Dubois","year":"2021","unstructured":"Dubois B, Villain N, Frisoni GB, Rabinovici GD, Sabbagh M, Cappa S, et al. Clinical diagnosis of alzheimer\u2019s disease: recommendations of the international working group. Lancet Neurol. 2021;20:484\u201396. https:\/\/doi.org\/10.1016\/S1474-4422(21)00066-1.","journal-title":"Lancet Neurol"},{"key":"4742_CR2","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S1474-4422(04)00710-0","volume":"3","author":"B Dubois","year":"2004","unstructured":"Dubois B, Albert ML. Amnestic MCI or prodromal alzheimer\u2019s disease? Lancet Neurol. 2004;3:246\u20138. https:\/\/doi.org\/10.1016\/S1474-4422(04)00710-0.","journal-title":"Lancet Neurol"},{"key":"4742_CR3","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1016\/s0197-4580(97)00062-6","volume":"18","author":"H Braak","year":"1997","unstructured":"Braak H, Braak E. Diagnostic criteria for neuropathologic assessment of alzheimer\u2019s disease. Neurobiol Aging. 1997;18:S85\u20138. https:\/\/doi.org\/10.1016\/s0197-4580(97)00062-6.","journal-title":"Neurobiol Aging"},{"key":"4742_CR4","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1093\/brain\/awv236","volume":"138","author":"H Braak","year":"2015","unstructured":"Braak H, Del Tredici K. The preclinical phase of the pathological process underlying sporadic alzheimer\u2019s disease. Brain. 2015;138:2814\u201333. https:\/\/doi.org\/10.1093\/brain\/awv236.","journal-title":"Brain"},{"key":"4742_CR5","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/s41398-021-01602-5","volume":"11","author":"S-D Chen","year":"2021","unstructured":"Chen S-D, Lu J-Y, Li H-Q, Yang Y-X, Jiang J-H, Cui M, et al. Staging Tau pathology with Tau PET in alzheimer\u2019s disease: a longitudinal study. Transl Psychiatry. 2021;11:483. https:\/\/doi.org\/10.1038\/s41398-021-01602-5.","journal-title":"Transl Psychiatry"},{"key":"4742_CR6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239\u201359. https:\/\/doi.org\/10.1007\/BF00308809.","journal-title":"Acta Neuropathol"},{"key":"4742_CR7","doi-asserted-by":"publisher","unstructured":"Raghuraman R, Aoun A, Herman M, Shetler CO, Nahmani E, Hussaini SA. Lateral entorhinal cortex dysfunction in Alzheimer\u2019s disease mice. bioRxiv. 2024. https:\/\/doi.org\/10.1101\/2024.04.15.589589.","DOI":"10.1101\/2024.04.15.589589"},{"key":"4742_CR8","doi-asserted-by":"publisher","first-page":"9811","DOI":"10.1523\/JNEUROSCI.1532-04.2004","volume":"24","author":"CA Buckmaster","year":"2004","unstructured":"Buckmaster CA, Eichenbaum H, Amaral DG, Suzuki WA, Rapp PR. Entorhinal cortex lesions disrupt the relational organization of memory in monkeys. J Neurosci. 2004;24:9811\u201325. https:\/\/doi.org\/10.1523\/JNEUROSCI.1532-04.2004.","journal-title":"J Neurosci"},{"key":"4742_CR9","doi-asserted-by":"publisher","first-page":"9850","DOI":"10.1523\/JNEUROSCI.1580-10.2010","volume":"30","author":"YS Jo","year":"2010","unstructured":"Jo YS, Lee I. Disconnection of the hippocampal-perirhinal cortical circuits severely disrupts object-place paired associative memory. J Neurosci. 2010;30:9850\u20138. https:\/\/doi.org\/10.1523\/JNEUROSCI.1580-10.2010.","journal-title":"J Neurosci"},{"key":"4742_CR10","doi-asserted-by":"publisher","first-page":"e1470","DOI":"10.1212\/WNL.0000000000011477","volume":"96","author":"AN Trelle","year":"2021","unstructured":"Trelle AN, Carr VA, Wilson EN, Swarovski MS, Hunt MP, Toueg TN, et al. Association of CSF biomarkers with Hippocampal-Dependent memory in preclinical alzheimer disease. Neurology. 2021;96:e1470\u201381. https:\/\/doi.org\/10.1212\/WNL.0000000000011477.","journal-title":"Neurology"},{"key":"4742_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-230026","volume":"93","author":"GG Fillenbaum","year":"2023","unstructured":"Fillenbaum GG, Mohs R. CERAD (Consortium to Establish a registry for alzheimer\u2019s Disease) neuropsychology assessment battery: 35 years and counting. J Alzheimers Dis. 2023;93:1\u201327. https:\/\/doi.org\/10.3233\/JAD-230026.","journal-title":"J Alzheimers Dis"},{"key":"4742_CR12","first-page":"641","volume":"24","author":"JC Morris","year":"1988","unstructured":"Morris JC, Mohs RC, Rogers H, Fillenbaum G, Heyman A. Consortium to Establish a registry for alzheimer\u2019s disease (CERAD) clinical and neuropsychological assessment of alzheimer\u2019s disease. Psychopharmacol Bull. 1988;24:641\u201352.","journal-title":"Psychopharmacol Bull"},{"key":"4742_CR13","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1159\/000357774","volume":"4","author":"NS Schmid","year":"2014","unstructured":"Schmid NS, Ehrensperger MM, Berres M, Beck IR, Monsch AU. The extension of the German CERAD neuropsychological assessment battery with tests assessing Subcortical, executive and frontal functions improves accuracy in dementia diagnosis. Dement Geriatr Cogn Dis Extra. 2014;4:322\u201334. https:\/\/doi.org\/10.1159\/000357774.","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"4742_CR14","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1212\/WNL.39.9.1159","volume":"39","author":"JC Morris","year":"1989","unstructured":"Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, et al. The consortium to Establish a registry for alzheimer\u2019s disease (CERAD). Part I. Clinical and neuropsychological assessment of alzheimer\u2019s disease. Neurology. 1989;39:1159\u201365. https:\/\/doi.org\/10.1212\/WNL.39.9.1159.","journal-title":"Neurology"},{"key":"4742_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189\u201398. https:\/\/doi.org\/10.1016\/0022-3956(75)90026-6.","journal-title":"J Psychiatr Res"},{"key":"4742_CR16","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1007\/s00115-022-01339-6","volume":"93","author":"R Hau\u00dfmann","year":"2022","unstructured":"Hau\u00dfmann R, Homeyer P, Brandt MD, Donix M. Prognostischer und differenzialdiagnostischer Stellenwert der liquordiagnostik Bei neurodegenerativen Demenzerkrankungen. [Prognostic and diagnostic value of cerebrospinal fluid analysis in neurodegenerative dementia diseases]. Nervenarzt. 2022;93:1236\u201342. https:\/\/doi.org\/10.1007\/s00115-022-01339-6.","journal-title":"Nervenarzt"},{"key":"4742_CR17","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1001\/archneurol.2008.596","volume":"66","author":"T Tapiola","year":"2009","unstructured":"Tapiola T, Alafuzoff I, Herukka S-K, Parkkinen L, Hartikainen P, Soininen H, Pirttil\u00e4 T. Cerebrospinal fluid {beta}-amyloid 42 and Tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch Neurol. 2009;66:382\u20139. https:\/\/doi.org\/10.1001\/archneurol.2008.596.","journal-title":"Arch Neurol"},{"key":"4742_CR18","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1001\/archneur.65.7.963","volume":"65","author":"SE O\u2019Bryant","year":"2008","unstructured":"O\u2019Bryant SE, Humphreys JD, Smith GE, Ivnik RJ, Graff-Radford NR, Petersen RC, Lucas JA. Detecting dementia with the mini-mental state examination in highly educated individuals. Arch Neurol. 2008;65:963\u20137. https:\/\/doi.org\/10.1001\/archneur.65.7.963.","journal-title":"Arch Neurol"},{"key":"4742_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1017\/S1041610218000704","volume":"31","author":"XY Chua","year":"2019","unstructured":"Chua XY, Choo RWM, Ha NHL, Cheong CY, Wee SL, Yap PLK. Mapping modified Mini-Mental state examination (MMSE) scores to dementia stages in a multi-ethnic Asian population. Int Psychogeriatr. 2019;31:147\u201351. https:\/\/doi.org\/10.1017\/S1041610218000704.","journal-title":"Int Psychogeriatr"},{"key":"4742_CR20","volume-title":"WMS-R: Wechsler memory Scale-Revised","author":"D Wechsler","year":"1987","unstructured":"Wechsler D. WMS-R: Wechsler memory Scale-Revised. New York: The Psychological Corporation; 1987."},{"key":"4742_CR21","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"AT Beck","year":"1961","unstructured":"Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561\u201371.","journal-title":"Arch Gen Psychiatry"},{"key":"4742_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3233\/JAD-2009-0931","volume":"16","author":"H Hildebrandt","year":"2009","unstructured":"Hildebrandt H, Haldenwanger A, Eling P. False recognition correlates with amyloid-beta (1\u201342) but not with total Tau in cerebrospinal fluid of patients with dementia and mild cognitive impairment. J Alzheimers Dis. 2009;16:157\u201365. https:\/\/doi.org\/10.3233\/JAD-2009-0931.","journal-title":"J Alzheimers Dis"},{"key":"4742_CR23","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/aje\/kwk052","volume":"165","author":"E Vittinghoff","year":"2007","unstructured":"Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165:710\u20138. https:\/\/doi.org\/10.1093\/aje\/kwk052.","journal-title":"Am J Epidemiol"},{"key":"4742_CR24","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3233\/JAD-150137","volume":"48","author":"P Mistridis","year":"2015","unstructured":"Mistridis P, Krumm S, Monsch AU, Berres M, Taylor KI. The 12 years preceding mild cognitive impairment due to alzheimer\u2019s disease: the Temporal emergence of cognitive decline. J Alzheimers Dis. 2015;48:1095\u2013107. https:\/\/doi.org\/10.3233\/JAD-150137.","journal-title":"J Alzheimers Dis"},{"key":"4742_CR25","unstructured":"Hildebrandt H. Neuropsychological tools for dementia: differential diagnosis and treatment. Academic Press, Elsevier; 2021."},{"key":"4742_CR26","volume-title":"Discovering statistics using SPSS: (and sex and drugs and rock \u2018n\u2019 roll)","author":"A Field","year":"2009","unstructured":"Field A. Discovering statistics using SPSS: (and sex and drugs and rock \u2018n\u2019 roll). 3rd ed. Los Angeles: Sage Publ; 2009.","edition":"3"},{"key":"4742_CR27","doi-asserted-by":"publisher","unstructured":"Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32\u20135. https:\/\/doi.org\/10.1002\/1097-0142(1950)3:1%3C32::AID-CNCR2820030106%3E3.0.CO;2-3.","DOI":"10.1002\/1097-0142(1950)3:1%3C32::AID-CNCR2820030106%3E3.0.CO;2-3"},{"key":"4742_CR28","doi-asserted-by":"publisher","first-page":"e0127272","DOI":"10.1371\/journal.pone.0127272","volume":"10","author":"G Shan","year":"2015","unstructured":"Shan G. Improved confidence intervals for the Youden index. PLoS ONE. 2015;10:e0127272. https:\/\/doi.org\/10.1371\/journal.pone.0127272.","journal-title":"PLoS ONE"},{"key":"4742_CR29","volume-title":"Multivariate analysemethoden: eine anwendungsorientierte Einf\u00fchrung","author":"K Backhaus","year":"2006","unstructured":"Backhaus K, Erichson B, Plinke W, Weiber R. Multivariate analysemethoden: eine anwendungsorientierte Einf\u00fchrung. 11th ed. Berlin, Heidelberg: Springer; 2006.","edition":"11"},{"key":"4742_CR30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1017\/S1355617701020069","volume":"8","author":"KS Fowler","year":"2002","unstructured":"Fowler KS, Saling MM, Conway EL, Semple JM, Louis WJ. Paired associate performance in the early detection of DAT. J Int Neuropsychol Soc. 2002;8:58\u201371.","journal-title":"J Int Neuropsychol Soc"},{"key":"4742_CR31","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1037\/neu0000561","volume":"33","author":"JE Baker","year":"2019","unstructured":"Baker JE, Pietrzak RH, Laws SM, Ames D, Villemagne VL, Rowe CC, et al. Visual paired associate learning deficits associated with elevated beta-amyloid in cognitively normal older adults. Neuropsychology. 2019;33:964\u201374. https:\/\/doi.org\/10.1037\/neu0000561.","journal-title":"Neuropsychology"},{"key":"4742_CR32","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1017\/S1041610220003841","volume":"33","author":"EB Hicks","year":"2021","unstructured":"Hicks EB, Ahsan N, Bhandari A, Ghazala Z, Wang W, Pollock BG, et al. Associations of visual paired associative learning task with global cognition and its potential usefulness as a screening tool for alzheimer\u2019s dementia. Int Psychogeriatr. 2021;33:1135\u201344. https:\/\/doi.org\/10.1017\/S1041610220003841.","journal-title":"Int Psychogeriatr"},{"key":"4742_CR33","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1001\/jamapsychiatry.2024.4305","volume":"3","author":"WA Wiels","year":"2025","unstructured":"Wiels WA, Oomens JE, Engelborghs S, Baeken C, von Arnim CAF, Boada M, et al. Depressive symptoms and amyloid pathology. JAMA Psychiatry. 2025;3:296\u2013310. https:\/\/doi.org\/10.1001\/jamapsychiatry.2024.4305.","journal-title":"JAMA Psychiatry"},{"key":"4742_CR34","doi-asserted-by":"publisher","first-page":"e12584","DOI":"10.1002\/dad2.12584","volume":"16","author":"C Crump","year":"2024","unstructured":"Crump C, Sieh W, Vickrey BG, Edwards AC, Sundquist J, Sundquist K. Risk of depression in persons with alzheimer\u2019s disease: A National cohort study. Alzheimers Dement (Amst). 2024;16:e12584. https:\/\/doi.org\/10.1002\/dad2.12584.","journal-title":"Alzheimers Dement (Amst)"},{"key":"4742_CR35","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.17r11772","author":"MS Asmer","year":"2018","unstructured":"Asmer MS, Kirkham J, Newton H, Ismail Z, Elbayoumi H, Leung RH, Seitz DP. Meta-Analysis of the prevalence of major depressive disorder among older adults with dementia. J Clin Psychiatry. 2018. https:\/\/doi.org\/10.4088\/JCP.17r11772.","journal-title":"J Clin Psychiatry"},{"key":"4742_CR36","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2217\/nmt-2022-0001","volume":"12","author":"SB Bareeqa","year":"2022","unstructured":"Bareeqa SB, Samar SS, Kamal S, Masood Y, Allahyar, Ahmed SI, Hayat G. Prodromal depression and subsequent risk of developing parkinson\u2019s disease: a systematic review with meta-analysis. Neurodegener Dis Manag. 2022;12:155\u201364. https:\/\/doi.org\/10.2217\/nmt-2022-0001.","journal-title":"Neurodegener Dis Manag"},{"key":"4742_CR37","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1037\/neu0000836","volume":"37","author":"LM Wright","year":"2023","unstructured":"Wright LM, de Marco M, Venneri A. Verbal fluency discrepancies as a marker of the prehippocampal stages of alzheimer\u2019s disease. Neuropsychology. 2023;37:790\u2013800. https:\/\/doi.org\/10.1037\/neu0000836.","journal-title":"Neuropsychology"},{"key":"4742_CR38","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3988\/jcn.2022.0358","volume":"19","author":"S Kang","year":"2023","unstructured":"Kang S, Yoon SH, Na HK, Lee Y-G, Jeon S, Baik K, et al. Neuropsychological comparison of patients with alzheimer\u2019s disease and dementia with lewy bodies. J Clin Neurol. 2023;19:521\u20139. https:\/\/doi.org\/10.3988\/jcn.2022.0358.","journal-title":"J Clin Neurol"},{"key":"4742_CR39","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1017\/S1355617721001144","volume":"28","author":"A Delgado-\u00c1lvarez","year":"2022","unstructured":"Delgado-\u00c1lvarez A, Cabrera-Mart\u00edn MN, Pytel V, Delgado-Alonso C, Mat\u00edas-Guiu J, Matias-Guiu JA. Design and verbal fluency in alzheimer\u2019s disease and frontotemporal dementia: clinical and metabolic correlates. J Int Neuropsychol Soc. 2022;28:947\u201362. https:\/\/doi.org\/10.1017\/S1355617721001144.","journal-title":"J Int Neuropsychol Soc"},{"key":"4742_CR40","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00415-025-13171-4","volume":"272","author":"A Facchin","year":"2025","unstructured":"Facchin A, Buonocore J, Sgr\u00f2 G, Cristofaro A, Cras\u00e0 M, Camastra C, et al. Eye movement abnormalities in normal pressure hydrocephalus: a video-oculographic study. J Neurol. 2025;272:425. https:\/\/doi.org\/10.1007\/s00415-025-13171-4.","journal-title":"J Neurol"},{"key":"4742_CR41","doi-asserted-by":"publisher","first-page":"1267434","DOI":"10.3389\/fnagi.2023.1267434","volume":"15","author":"L Sokolovi\u010d","year":"2023","unstructured":"Sokolovi\u010d L, Hofmann MJ, Mohammad N, Kukolja J. Neuropsychological differential diagnosis of alzheimer\u2019s disease and vascular dementia: a systematic review with meta-regressions. Front Aging Neurosci. 2023;15:1267434. https:\/\/doi.org\/10.3389\/fnagi.2023.1267434.","journal-title":"Front Aging Neurosci"},{"key":"4742_CR42","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.jclinepi.2011.06.013","volume":"64","author":"DS Courvoisier","year":"2011","unstructured":"Courvoisier DS, Combescure C, Agoritsas T, Gayet-Ageron A, Perneger TV. Performance of logistic regression modeling: beyond the number of events per variable, the role of data structure. J Clin Epidemiol. 2011;64:1463\u20134. https:\/\/doi.org\/10.1016\/j.jclinepi.2011.06.013.","journal-title":"J Clin Epidemiol"},{"key":"4742_CR43","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.jclinepi.2011.06.016","volume":"64","author":"EW Steyerberg","year":"2011","unstructured":"Steyerberg EW, Schemper M, Harrell FE. Logistic regression modeling and the number of events per variable: selection bias dominates. J Clin Epidemiol. 2011;64:1643\u20131469. https:\/\/doi.org\/10.1016\/j.jclinepi.2011.06.016.","journal-title":"J Clin Epidemiol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-04742-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04742-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04742-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:28:08Z","timestamp":1781638088000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-04742-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4742"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-04742-7","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The retrospective re-evaluation project was approved by the ethics committee of the medical board of Bremen (number 905\/ 2024) and was performed in accordance with the ethical standards of the Declaration of Helsinki. The informed consent was not necessary due to the retrospective nature of the study, according to \u00a739 BremKrhG.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"T.D.: Professional fee for speeches and travel support: Genzyme, Shire, Bristol-Myers Squibb, Boehringer-Ingelheim Pharma, Sanofi Aventis, Eisai, Novartis, Bayer Vital, Merz Pharma, Actelion, Lundbeck, Amicus, Merck-Serono, Lilly, Berlin-Chemie, Roche, Biogen. Advisory fee: Genzyme, Shire, Bristol-Myers Squibb, AstraZeneca, Actelion, Amicus, Novar-tis, Teva, Roche, Biogen. Research fundings: Amicus, Genzyme, Shire, Actelion, Novartis, Roche, Biogen. F.K., A.N., M.R., H.H.: Nothing to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"228"}}